A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease

计划入组 38 人 · 首次发布于 2012 年 1 月 5 日

Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use Disorders

计划入组 30 人 · 首次发布于 2022 年 5 月 17 日

A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease

计划入组 40 人 · 首次发布于 2025 年 12 月 16 日

liver disease program

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

non-alcoholic fatty liver disease agent

ALCOHOL RESEARCH UK

United Kingdom

LIVER INSTITUTE PLLC

United States

National Liver Institute

Egypt

Altimmune Expands Pemvidutide Testing to Alcohol Use Disorder and Liver Disease

Oracle and Baylor College of Medicine Launch Major AI-Driven Research Initiative to Combat Rising Alcohol-Related Liver Disease

Rising Liver Cancer Cases in the US Linked to Alcohol-Associated Liver Disease and MASLD